Ethacrynic acid is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Alvogen, Inc.. The primary component is Ethacrynic Acid.
| Product ID | 47781-497_18a88442-5dde-c9ff-c93d-3dea14a94b08 |
| NDC | 47781-497 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Ethacrynic acid |
| Generic Name | Ethacrynic Acid |
| Dosage Form | Tablet |
| Route of Administration | ORAL |
| Marketing Start Date | 2018-07-24 |
| Marketing Category | ANDA / ANDA |
| Application Number | ANDA205709 |
| Labeler Name | Alvogen, Inc. |
| Substance Name | ETHACRYNIC ACID |
| Active Ingredient Strength | 25 mg/1 |
| Pharm Classes | Increased Diuresis at Loop of Henle [PE],Loop Diuretic [EPC] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2021-12-31 |
| Marketing Start Date | 2018-07-24 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | ANDA |
| Application Number | ANDA205709 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | EA |
| Marketing Start Date | 2018-07-24 |
| Ingredient | Strength |
|---|---|
| ETHACRYNIC ACID | 25 mg/1 |
| SPL SET ID: | b0ff876d-39ff-ca70-074b-285028d827ed |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 0054-0415 | Ethacrynic Acid | Ethacrynic Acid |
| 0832-1690 | Ethacrynic Acid | Ethacrynic Acid |
| 42799-405 | Ethacrynic Acid | Ethacrynic Acid |
| 47781-497 | Ethacrynic acid | ethacrynic acid |
| 49884-276 | Ethacrynic Acid | Ethacrynic Acid |
| 50228-334 | Ethacrynic Acid | Ethacrynic Acid |
| 52817-367 | Ethacrynic acid | Ethacrynic acid |
| 60429-887 | Ethacrynic Acid | Ethacrynic Acid |
| 64380-909 | ETHACRYNIC ACID | ethacrynic acid |
| 68180-159 | Ethacrynic Acid | Ethacrynic Acid |
| 68682-011 | ethacrynic acid | ethacrynic acid |
| 69238-1126 | Ethacrynic Acid | Ethacrynic Acid |
| 72134-003 | Ethacrynic acid | Ethacrynic acid |
| 25010-215 | EDECRIN | ethacrynic acid |
| 69189-0371 | EDECRIN | ethacrynic acid |